DRUG · Unmapped registry intervention
Intravenous Sildenafil
Find medicine records ·
Find other trials using this name
Clinical trial
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
NCT01409031
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Persistent Pulmonary Hypertensionunresolved
Interventions
PlaceboOTHER
Sponsors & collaborators
University of Colorado, Denverlead sponsor
State University of New York at Buffalocollaborator
Vanderbilt Universitycollaborator
University of Utahcollaborator
University of Alabama at Birminghamcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01409031 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.